Enroll in Heart Failure & Pulmonary Hypertension Clinical Trials in Sherman, Texas!
Heart failure (HF) with preserved ejection fraction (HFpEF) is the most frequently occurring subtype of heart failure (WHO Class 2) and it comprises up to 50% of all heart failure cases. Elevated left atrial pressure can cause congestion in the pulmonary veins, which can lead to increased pulmonary pressure (or pulmonary hypertension) and right ventricular (RV) failure. This can result in low cardiac output, edema, hypoxemia, and severely limited exercise capacity.
Revival Research Institute is conducting heart failure and pulmonary hypertension clinical trials in Sherman, Texas. This clinical trial aims to study the safety and efficacy of an investigational therapy, that could potentially change the way pulmonary hypertension with heart failure is managed.
The eligibility criteria to participate in the heart failure and pulmonary hypertension clinical trials in Sherman, Texas:
- Males and females 18 to 85 years of age
- Diagnosed with heart failure
- Have pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF)
*Additional criteria may apply
*If you are interested in participating in the clinical trial or know someone who is, please feel free to get in touch with us by filling out the form. Someone from the study team will call you to complete the screening process. Your well-being and health will be our main priority throughout the duration of the study.
**Participation in clinical trials is free of cost to you and your health insurance.
***Filling the form does not mean that you must join the study or that you will be able to participate.